canada clinical guidance

Obstructive sleep apnoea (OSAHS) + obesity hypoventilation

A Canadian clinical summary of obstructive sleep apnoea (osahs) + obesity hypoventilation, with source-attributed priorities and explicit jurisdiction boundaries.

JurisdictionCanada
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceHealthcare professionals practising in Canada
This is an iatroX educational summary of named Canada sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.

Source and scope

This summary is bounded to the recommendations, population and decisions covered by Diagnosis and treatment of sleep disordered breathing in adults. Apply it with the current provincial or territorial pathway where implementation differs.
sources for this section:CTS sleep

Source-attributed clinical priorities

  • Assess symptoms, cardiometabolic risk, occupation and safety rather than using snoring alone to infer obstructive sleep apnea.
  • Confirm the diagnosis with an appropriate sleep study selected for pre-test probability and comorbidity.
  • Address driving risk and offer weight, airway and positive-airway-pressure interventions according to phenotype and local sleep-service access.
  • Ask specifically about drowsy driving and safety-sensitive work when sleep apnea is suspected.
sources for this section:CTS sleep

Practical assessment and management workflow

1
Record snoring, witnessed apneas, sleepiness, sleep duration, sedatives, weight and cardiopulmonary comorbidity.
2
Estimate pre-test probability and select home testing or polysomnography for the clinical context.
3
Discuss positive-airway-pressure, oral-appliance, weight and upper-airway options after diagnostic confirmation.
4
Monitor adherence, residual symptoms, mask problems and cardiometabolic risk after treatment starts.
sources for this section:CTS sleep

Safety, red flags and urgent escalation

  • Restrict driving when sleepiness creates an immediate safety risk under the applicable licensing rules.
  • Do not use a screening questionnaire alone to establish or exclude the diagnosis.
  • Use laboratory polysomnography rather than limited testing when important comorbidity makes home testing unreliable.
sources for this section:CTS sleep

Confirm the local pathway before acting

The evidence source is pan-Canadian, but formularies, funded access, referral routes, public-health directions and service availability remain provincial or territorial.
sources for this section:CTS sleep

Source and implementation boundary

Read this educational summary with the linked source, current Canadian product information where medicines are involved, and the applicable provincial or territorial pathway. Local formularies, reporting duties, referral routes and service availability can differ.
sources for this section:CTS sleep

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. Canadian Thoracic SocietyDiagnosis and treatment of sleep disordered breathing in adultsaccessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Found a source update or regional discrepancy? Tell the iatroX editorial team.